Cargando…
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literatu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431775/ https://www.ncbi.nlm.nih.gov/pubmed/32849195 http://dx.doi.org/10.3389/fneur.2020.00716 |
_version_ | 1783571655189069824 |
---|---|
author | Egeo, Gabriella Fofi, Luisa Barbanti, Piero |
author_facet | Egeo, Gabriella Fofi, Luisa Barbanti, Piero |
author_sort | Egeo, Gabriella |
collection | PubMed |
description | Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literature regarding its effect on neuropathic pain. Almost all investigations were performed using onabotulinum toxin type A (BoNT/A). Most studies provided positive results, even though toxin formulation, dose, dilution, injection techniques, and sites are heterogeneous across studies. Future larger, high-quality, specifically designed clinical trials are warranted to confirm botulinum neurotoxin efficacy in neuropathic pain. |
format | Online Article Text |
id | pubmed-7431775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74317752020-08-25 Botulinum Neurotoxin for the Treatment of Neuropathic Pain Egeo, Gabriella Fofi, Luisa Barbanti, Piero Front Neurol Neurology Botulinum neurotoxin is widely used for the treatment of central and peripherical neurological conditions. Initially used to treat strabismus, over the years its use has been expanded also to spasticity and other neurological disorders. This review summarizes the evidence from the published literature regarding its effect on neuropathic pain. Almost all investigations were performed using onabotulinum toxin type A (BoNT/A). Most studies provided positive results, even though toxin formulation, dose, dilution, injection techniques, and sites are heterogeneous across studies. Future larger, high-quality, specifically designed clinical trials are warranted to confirm botulinum neurotoxin efficacy in neuropathic pain. Frontiers Media S.A. 2020-08-11 /pmc/articles/PMC7431775/ /pubmed/32849195 http://dx.doi.org/10.3389/fneur.2020.00716 Text en Copyright © 2020 Egeo, Fofi and Barbanti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Egeo, Gabriella Fofi, Luisa Barbanti, Piero Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title | Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title_full | Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title_fullStr | Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title_full_unstemmed | Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title_short | Botulinum Neurotoxin for the Treatment of Neuropathic Pain |
title_sort | botulinum neurotoxin for the treatment of neuropathic pain |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431775/ https://www.ncbi.nlm.nih.gov/pubmed/32849195 http://dx.doi.org/10.3389/fneur.2020.00716 |
work_keys_str_mv | AT egeogabriella botulinumneurotoxinforthetreatmentofneuropathicpain AT fofiluisa botulinumneurotoxinforthetreatmentofneuropathicpain AT barbantipiero botulinumneurotoxinforthetreatmentofneuropathicpain |